Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy
- PMID: 20160209
- PMCID: PMC3641161
- DOI: 10.1176/jnp.2010.22.1.48
Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy
Abstract
The authors examined the long-term cognitive implications of cancer treatment among breast cancer survivors over 65 years old who received treatment during midlife. Thirty women survivors were matched with 30 noncancer, healthy older adults in terms of age, education, and IQ. The cancer survivors scored significantly lower in the cognitive domains of executive functioning, working memory, and divided attention, reflecting potential dysfunction in frontal-subcortical brain regions. Our findings suggest that among breast cancer survivors who remain disease-free for more than a decade, the previous cancer treatment may further augment cognitive dysfunction associated with age-related brain changes.
References
-
- Ries LAG, Melbert D, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975–2004. Bethesda, Md: National Cancer Institute; 2007.
-
- Ahles TA, Saykin AS. Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Invest. 2001;19:812–820. - PubMed
-
- Olin JJ. Cognitive function after systemic therapy for breast cancer. Oncology. 2001;15:613–624. - PubMed
-
- Anderson-Hanley C, Sherman ML, Riggs R, et al. Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. JINS. 2003;9:967–982. - PubMed
-
- Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
